Title List مقالات لاتين Cardiomyopathy in infancy and postmortem di diagnosis of a fatty acid oxidation defect Caregiver Burden and Quality of Life among Caregivers of Cancer Patients in Ahvaz, 2021 - 2022: A Cross-Sectional Study

بر اساس عنوان

1

Cardiomyopathy in infancy and postmortem di diagnosis of a fatty acid oxidation defect

2

Cardiomyopathy in neurological disorders

3

CARDIOMYOPATHY IN PATIENTS INFECTED WITH HUMAN IMMUNE DEFICIENCY VIRUS.

4

Cardiomyopathy in rats with Walker 256 tumor: The potential role of microvascular disease in its genesis

5

Cardiomyopathy with a unique finding of bicuspid aortic valve in Beckerʹs muscular dystrophy

6

Cardiomyopathy with Pancytopenia in a Pregnancy: Case Reports

7

Cardiomyopathy, nephropathy, and death in a 44-year-old man

8

Cardiomyopathy: a role for nitric oxide?

9

Cardiomyoplasty — Improvement of Muscle Fibre Type Transformation by an Anabolic Steroid (Metenolone)

10

Cardiomyoplasty after implantation of a pacemaker and cardioverter/defibrillator

11

Cardiomyoplasty reduces myocardial oxygen consumption: implications for direct mechanical compression

12

Cardiomyoplasty: Is it time to wrap it up?

13

Cardiomyoplasty: the benefits of electrical prestimulation of the latissimus dorsi muscle in situ

14

Cardio-Oesophageal Reflex: Mechanism for “Linked Angina” in Patients with Angiographically Proven Coronary Artery Disease

15

Cardio-Oncology in Iran: Cardio-toxicity Registry

16

Cardiopetalolactone: A Novel Styryllactone from Goniothalamus cardiopetalus

17

Cardioplegia and Diazoxide Modulate STAT3 Activation and DNA Binding

18

Cardioplegia and ischemia in the canine heart evaluated by 31P magnetic resonance spectroscopy

19

Cardioplegia in pediatric cardiac surgery: do we believe in magic?

20

Cardioplegia preserves hypoxic response in isolated coronary arteries but not in isolated hearts

21

Cardioplegia protection against ischemia-reperfusion failure: Role of both modes of Na/Ca-exchanger and sarcoplasmic reticulum

22

Cardioplegia-induced cell swelling: prevention by normothermic infusion

23

Cardioplegic arrest with image-arginine improves myocardial protection: results of a prospective randomized clinical trial

24

Cardioplegic ischemia or reperfusion: Which is a main trigger for tumor necrosis factor production?

25

Cardiopoiesis: Cardiac myocyte creation by adult and embryonic cells

26

Cardiopoietic Stem Cell Therapy in Heart Failure: The C-CURE (Cardiopoietic stem Cell therapy in heart failURE) Multicenter Randomized Trial With Lineage-Specified Biologics

27

Cardiopoietry in Motion: Primed Mesenchymal Stem Cells for Ischemic Cardiomyopathy

28

Cardioprotection and garlic

29

Cardioprotection and garlic

30

Cardioprotection and garlic

31

Cardioprotection and garlic

32

Cardioprotection and mitochondrial S-nitrosation: Effects of S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) in cardiac ischemia–reperfusion injury

33

Cardioprotection at a Distance: Mesenteric Artery Occlusion Protects the Myocardium via an Opioid Sensitive Mechanism

34

Cardioprotection before revascularization in ischemic myocardial injury and the potential role of hemoglobin-based oxygen carriers

35

Cardioprotection by 3-iodothyronamine, a new endogenous chemical messenger

36

Cardioprotection by Activation of NO/cGMP Pathway After Cardioplegic Arrest and 8-Hour Storage

37

Cardioprotection by Cyclosporine A in Experimental Ischemia and Reperfusion—Evidence for a Nitric Oxide-dependent Mechanism Mediated by Endothelin

38

Cardioprotection by Ischemic Preconditioning Preserves Mitochondrial Function and Functional Coupling Between Adenine Nucleotide Translocase and Creatine Kinase

39

Cardioprotection by Local Heating: Improved Myocardial Salvage After Ischemia and Reperfusion

40

Cardioprotection by Orotic Acid: Metabolism and Mechanism of Action

41

Cardioprotection by Volatile Anesthetics in Noncardiac Surgery? No, Not Yet At Least

42

Cardioprotection During Chemotherapy: Need for Faster Transfer of Knowledge From Cardiology to Oncology and Role for a Cardio-Oncologist

43

Cardioprotection Effects of Sevoflurane by Regulating the Pathway of Neuroactive Ligand-Receptor Interaction in Patients Undergoing Coronary Artery Bypass Graft Surgery

44

Cardioprotection for Duchenne’s muscular dystrophy, ,

45

Cardioprotection from ischaemia–reperfusion injury: Dissecting the PI3K/AKT pathway with chemical inhibition of PTEN

46

Cardioprotection in aged myocardium: Sites of failure in protective signalling

47

Cardioprotection induced in response to preconditioning is lost after an initral iscraemic insult

48

Cardioprotection of bradykinin at reperfusion in isolated rat hearts requires a transactivation of the EGF receptor

49

Cardioprotection of trimetazidine and anthracycline-induced acute cardiotoxic effects

50

Cardioprotection with phosphodiesterase-5 inhibition—a novel preconditioning strategy

51

Cardioprotection: A New Paradigm in the Management of Acute Heart Failure Syndromes

52

Cardioprotection: Intermittent Ventricular Fibrillation and Rapid Pacing Can Induce Preconditioning in the Blood-perfused Rat Heart

53

Cardioprotective Actions of Verapamil on theβ-Adrenergic Receptor Complex in Acute Canine Chagasʹ Disease

54

Cardioprotective activity of melatonin and its novel synthesized derivatives on doxorubicin-induced cardiotoxicity Original Research Article

55

Cardio-protective and anti-cancer therapeutic potential of Nigella sativa

56

Cardioprotective and antioxidant activities of a polysaccharide from the root bark of Aralia elata (Miq.) Seem

57

Cardioprotective and Anti-oxidant Effects of the Terpenoid Constituents ofGinkgo bilobaExtract (EGb 761)

58

Cardio-protective and cholesterol lowering effects of garlic (Allium sativum) and ginger (Zingiber officiale) extracts in laboratory animals

59

Cardioprotective and Hepatoprotective Activity of Silymarin in Broiler Chickens Fed on Mash and Pellet Diets

60

Cardioprotective and neuroprotective roles of oleuropein in olive

61

Cardioprotective and neuroprotective roles of oleuropein in olive

62

Cardioprotective Effect by Tumor Necrosis Factor-α and Interleukin-6 through Late Preconditioning in Unstable Angina Patients

63

Cardioprotective effect of aqueous extract of Chichorium intybus L. on ischemia-reperfusion injury in isolated rat heart

64

Cardioprotective effect of Azadirachta indica A. Juss. on isoprenaline induced myocardial infarction in rats

65

Cardioprotective Effect of Beta-3 Adrenergic Receptor Agonism: Role of Neuronal Nitric Oxide Synthase

66

Cardioprotective effect of cedrol in an inflammation systemic model induced by lipopolysaccharide: Biochemical and histological verification

67

Cardioprotective effect of chronic hypoxia is blunted by hypercapnia

68

Cardioprotective effect of chronic low dose ethanol drinking: Insights into the concept of ethanol preconditioning

69

Cardioprotective Effect of Cold-Blood Cardioplegia Enriched with N-Acetylcysteine During Coronary Artery Bypass Grafting

70

Cardioprotective effect of diazepam on ischemia-reperfused isolated hyperthyroid rat heart

71

Cardioprotective Effect of Ethanolic Leaf Extract of Melissa Officinalis L Against Regional Ischemia-Induced Arrhythmia and Heart Injury after Five Days of Reperfusion in Rats

72

Cardioprotective Effect of Extended Remote Ischemic Preconditioning in Patients Undergoing Coronary Artery Bypass Grafting: A Randomized Clinical Trial

73

Cardioprotective effect of fasting on ischemia reperfused rat heart after diazepam administration

74

Cardioprotective Effect of Garlic Juice on the Isolated Rat Heart in Ischemia- Reperfusion

75

Cardioprotective Effect of Glucagon Like Peptide-1 Receptor During Reperfusion of Isolated Ischemic Rat Heart Involves AMP-Activated Protein Kinase (AMPK) and Akt Signaling Pathways

76

Cardioprotective Effect of Grape Seed Extract on Chronic Doxorubicin-Induced Cardiac Toxicity in Wistar Rats

77

Cardioprotective effect of grape seed proanthocyanidins on isoproterenol-induced myocardial injury in rats

78

Cardioprotective effect of growth hormone secretagogues in rat heart

79

Cardioprotective Effect of High Intensity Interval Training and Nitric Oxide Metabolites (NO2-, NO3-)

80

Cardioprotective Effect of High-Intensity Aerobic Interval Training against Adriamycin-Induced Cardiac Toxicity in Rats

81

Cardioprotective effect of intermittent fasting is associated with an elevation of adiponectin levels in rats

82

Cardioprotective effect of lipstatin derivative orlistat on normotensive rats submitted to cardiac ischemia and reperfusion

83

Cardioprotective effect of preconditioning is more efficient than postconditioning in rats submitted to cardiac ischemia and reperfusion

84

Cardioprotective Effect of Quercetin against Ischemia/Reperfusion Injury Is Mediated Through NO System and Mitochondrial KATP Channels

85

Cardioprotective effect of Rosa canina L. methanolic extract on heat shock induced cardiomyocyte injury: An experimental study

86

Cardioprotective effect of royal jelly on paclitaxel-induced cardio-toxicity in rats

87

Cardioprotective Effect of Saffron Extract and Safranal in Isoproterenol-Induced Myocardial Infarction in Wistar Rats

88

Cardioprotective effect of selenium via modulation of cardiac ryanodine receptor calcium release channels in diabetic rat cardiomyocytes through thioredoxin system

89

Cardioprotective effect of vanillic acid against doxorubicin-induced cardiotoxicity in rat

90

CARDIOPROTECTIVE EFFECTS AND MECHANISM OF ACTION OF POLYPHENOLS EXTRACTED FROM PROPOLIS AGAINST DOXORUBICIN TOXICITY

91

Cardioprotective effects and molecular mechanisms of G-CSF on LV remodeling and dysfunction after AMI

92

Cardioprotective Effects of 17β-Estradiol Produced by Activation of Mitochondrial ATP-Sensitive K+Channels in Canine Hearts

93

Cardioprotective effects of a proanthocyanidin-rich fraction from Croton celtidifolius Baill: Focus on atherosclerosis

94

Cardioprotective effects of an early invasive strategy for non–ST-segment elevationacute coronary syndromes: Are we all becoming “interventional” cardiologists?

95

Cardioprotective effects of atorvastatin plus trimetazidine in percutaneous coronary intervention

96

Cardioprotective effects of bosentan, a mixed ETA/ETB Receptor antagonist on myocardial ischemic and reperfusion injury in cats

97

Cardioprotective effects of co-administration of thymoquinone and ischemic postconditioning in diabetic rats

98

Cardioprotective Effects of Coenzyme Q10 Supplementation on Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

99

Cardioprotective Effects of Curcumin Co-treatment in Rats With Establishing Chronic Variable Stress Stereology Study

100

Cardioprotective Effects of Essential Oil of Lavandula angustifolia on Isoproterenol-induced Acute Myocardial Infarction in Rat

101

Cardioprotective effects of Fenugreek (Trigonella foenum-graceum) seed extract in streptozotocin induced diabetic rats

102

Cardioprotective effects of FK409, a nitric oxide donor, after isolated rat heart preservation for 16 hours

103

Cardioprotective effects of Ganoderma lucidum on isoproterenol–induced heart failure

104

Cardioprotective effects of granulocyte colony-stimulating factor in swine with chronic myocardial ischemia

105

Cardioprotective Effects of Granulocyte Colony-Stimulating Factor in Swine With Chronic Myocardial Ischemia Original Research Article

106

Cardioprotective Effects of Grape Seed Proanthocyanidin Against Ischemic Reperfusion Injury

107

Cardioprotective effects of Ilex paraguariensis extract: evidence for a nitric oxide-dependent mechanism

108

Cardioprotective effects of iroxanadine: Role of nitric oxide, reactive oxygen species and heat-shock proteins

109

cardioprotective effects of mebudipine in a rat model of doxorubicin-induced heart failure

110

Cardioprotective Effects of Methanolic Extract of Scrophularia frigida on Ischemia-Reperfusion-Induced Injuries in Isolated Rat Heart

111

cardioprotective effects of octreotide against sepsis-induced cardiotoxicity in mice

112

Cardioprotective effects of pharmacologic preconditioning by natural honey against ischemia/reperfusion injury

113

Cardioprotective effects of pomegranate juice against ischemia and reperfusion in isolated rat heart

114

Cardioprotective Effects of Potassium Channel Openers on Rat Atria and Isolated Hearts under Acute Hypoxia

115

Cardioprotective effects of preinfarction angina in elderly: same patients, different results?

116

Cardioprotective Effects of Rosmarinic Acid on IsoproterenolInduced Myocardial Infarction in Rats

117

Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention

118

Cardioprotective effects of the NHE1-inhibitor EMD 87580

119

Cardioprotective efficacy of ischemic preconditioning on long-term myocardial ischemia

120

Cardioprotective Function of Inducible Nitric Oxide Synthase and Role of Nitric Oxide in Myocardial Ischemia and Preconditioning: an Overview of a Decade of Research

121

Cardioprotective mechanisms of sour cherry seed extract against ischemia/reperfusion-induced damage in isolated rat hearts

122

Cardioprotective Medication Is Associated With Improved Survival in Patients With Peripheral Arterial Disease Original Research Article

123

Cardioprotective Potential of Antihypertensives

124

Cardioprotective potential of biobased gold nanoparticles

125

Cardioprotective Potential of Celastrol in Sepsis-Induced Cardiotoxicity; Mouse Model of Endotoxemia

126

Cardioprotective Potential of Gemmomodified Extract of Terminalia arjuna against Chemically Induced Myocardial Injury in Rabbits

127

Cardio-protective properties of Momordica charantia in Albino Rats

128

Cardioprotective role of biosynthesized gold nanoparticles compared to an iodinated-based x-ray contrast agent in Male Wistar Rats

129

Cardioprotective role of FGF2 in a murine model of low-flow ischemia

130

Cardio-Protective Role of Gingerol along with Prominent Anti-Diabetic Cardiomyopathy Action in A Streptozotocin-Induced Diabetes Mellitus Rat Model StreptozotocinInduced Diabetes Mellitus Rat Model

131

Cardioprotective therapy and sodium-hydrogen exchange inhibition: current concepts and future goals

132

Cardiopulmonary and Systemic Effects of Methylprednisolone in Patients Undergoing Cardiac Surgery

133

Cardiopulmonary Arrest Outcome in Nemazee Hospital, Southern Iran

134

CARDIOPULMONARY ARREST SECONDARY TO HALOPERIDOL

135

CARDIO-PULMONARY ASSESSMENT IN PATIENTS WITH BETA THALASSEMIA

136

Cardiopulmonary bypass affects cognitive brain function after coronary artery bypass grafting

137

Cardiopulmonary Bypass Alone Does Not Cause Postoperative Cognitive Dysfunction Following Open Heart Surgery

138

Cardiopulmonary bypass alters vasomotor regulation of the skeletal muscle microcirculation

139

Cardiopulmonary bypass and oxygen consumption: oxygen delivery and hemodynamics

140

Cardiopulmonary bypass as a cause of free radical-induced oxidative stress and enhanced blood-borne isoprostanes in humans

141

Cardiopulmonary Bypass Circuit Treated With Surface-Modifying Additives: A Clinical Evaluation of Blood Compatibility

142

Cardiopulmonary bypass during pregnancy

143

Cardiopulmonary bypass for resuscitation after penetrating cardiac trauma

144

Cardiopulmonary bypass in a gravid patient: perioperative changes in endothelin levels

145

Cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia II and impaired renal function using heparin and the platelet GP IIb/IIIa inhibitor tirofiban as anticoagulant

146

Cardiopulmonary bypass in humans: bypassing unfractionated heparin

147

Cardiopulmonary bypass in man: role of the intestine in a self-limiting inflammatory response with demonstrable bacterial translocation

148

Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia and thrombosis

149

Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using org 10172

150

Cardiopulmonary bypass in pregnancy

151

Cardiopulmonary bypass induces the synthesis and release of matrix metalloproteinases

152

Cardiopulmonary bypass perfusion temperature does not influence perioperative renal function

153

Cardiopulmonary bypass support for emergency cesarean delivery in a patient with severe pulmonary hypertension

154

Cardiopulmonary bypass temperature, hematocrit, and cerebral oxygen delivery in humans

155

Cardiopulmonary Bypass Time Does Not Affect Cerebral Blood Flow

156

Cardiopulmonary Bypass With Bivalirudin in Type II Heparin-Induced Thrombocytopenia

157

Cardiopulmonary bypass with danaparoid sodium and ancrod in heparin-induced thrombocytopenia

158

Cardiopulmonary Bypass With Heparin-Coated Circuits and Reduced Systemic Anticoagulation

159

Cardiopulmonary Bypass, Inflammation and How to Defy it: Focus on Pharmacological Interventions

160

Cardiopulmonary bypass, rewarming, and central nervous system dysfunction

161

Cardiopulmonary bypass: Perioperative cerebral blood flow and postoperative cognitive deficit

162

Cardiopulmonary cerebral resuscitation using emergency cardiopulmonary bypass, coronary reperfusion therapy and mild hypothermia in patients with cardiac arrest outside the hospital

163

Cardiopulmonary effects of Detomidine-Propofol and Ketamine administration in the Donkeys

164

Cardiopulmonary effects of dorsal recumbency and high-volume caudal epidural anaesthesia with lidocaine or xylazine in calves

165

Cardiopulmonary effects of HI-6 treatment in soman intoxication

166

Cardiopulmonary effects of the anesthesia by romifidine as a premedication, midazolam and ketamine induction and infusion in donkeys

167

Cardiopulmonary effects of the laparoscopic pneumoperitoneum in a porcine model of adult respiratory distress syndrome

168

Cardiopulmonary exercise parameters in relation to all-cause mortality in patients with chronic heart failure

169

Cardiopulmonary exercise test evidence of isolated right coronary artery disease

170

Cardiopulmonary Exercise Test in Advanced Heart Failure Among Heart Transplantation Candidates

171

Cardiopulmonary exercise test in patients with subacute pulmonary emboli

172

Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited

173

Cardiopulmonary Exercise Testing and Six-Minute Walk Correlations in Pulmonary Arterial Hypertension

174

Cardiopulmonary exercise testing before and one year after mitral valve repair for severe mitral regurgitation

175

Cardiopulmonary Exercise Testing Determination of Functional Capacity in Mitral Regurgitation: Physiologic and Outcome Implications Original Research Article

176

Cardiopulmonary Exercise Testing Identifies Low Risk Patients With Heart Failure and Severely Impaired Exercise Capacity Considered for Heart Transplantation

177

Cardiopulmonary exercise testing in patients with heart failure

178

Cardiopulmonary Exercise Testing in the Clinical and Prognostic Assessment of Diastolic Heart Failure Original Research Article

179

Cardiopulmonary Exercise Variables in Diastolic Versus Systolic Heart Failure

180

Cardiopulmonary Function at Rest and During Exercise After Resection for Bronchial Carcinoma

181

Cardiopulmonary function in adult patients late after Fontan repair

182

Cardiopulmonary Functions of School Children in Oil-Spilled and Gas-Flared Niger- Delta and Rural-Riverine Lagos Communities

183

Cardiopulmonary hazards of perihepatic packing for major liver injuries,

184

Cardiopulmonary helminth parasites of red foxes (Vulpes vulpes) in Catalonia, northeastern Spain

185

Cardiopulmonary Limited Ultrasound Examination for “Quick-Look” Bedside Application

186

Cardiopulmonary Mortalities and Chronic Obstructive Pulmonary Disease Attributed to Ozone Air Pollution

187

Cardiopulmonary Mortalities and Chronic Obstructive Pulmonary Disease Attributed to Ozone Air Pollution

188

Cardiopulmonary mortality and air pollution

189

Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide

190

Cardiopulmonary Rehabilitation for Patients with Coronavirus Disease 2019 (COVID-19): A Narrative Review

191

Cardiopulmonary Response to Exercise and Cardiac Assessment in Patients With Turner Syndrome

192

Cardiopulmonary response to maximal exercise in young athletes following the Ross procedure

193

Cardiopulmonary Responses to Exercise and Its Utility in Patients With Aortic Stenosis

194

Cardiopulmonary responses to robotic end-effector-based walking and stair climbing

195

Cardiopulmonary Resuscitation (CPR) and Its Ethical Aspects

196

CARDIOPULMONARY RESUSCITATION : THE SHORT COMINGS IN MALAYSIA

197

Cardiopulmonary resuscitation and neurological complications in the elderly

198

Cardiopulmonary resuscitation by bystanders with chest compression only (SOS-KANTO): an observational study

199

Cardiopulmonary resuscitation by Emergency Medical Services in South Africa: Barriers to achieving high quality performance

200

Cardiopulmonary resuscitation directives on admission to intensive-care unit: an international observational study

201

Cardiopulmonary resuscitation in nursing homes

202

CARDIOPULMONARY RESUSCITATION IN THE LIGHT OFNEW 2010 AMERICAN HEART ASSOCIATION GUIDELINES: A SURVEY AMONG HEALTHCARE PROFESSIONALS OF TERTIARY CARE HOSPITALS IN PESHAWAR CITY

203

Cardiopulmonary resuscitation knowledge among nursing students: a questionnaire study

204

Cardiopulmonary resuscitation knowledge among nursing students: a questionnaire-based study

205

Cardiopulmonary Resuscitation Outcomes of Patients with COVID-19; a One-Year Survey

206

Cardiopulmonary Resuscitation Techniques and Instruction: When Does Evidence Justify Revision?, ,

207

Cardiopulmonary Resuscitation to Cardiocerebral Resuscitation: Difference Is Small for Statistical Significance but Large for Clinical Relevance

208

cardiopulmonary resuscitation training for medical students in anesthesiology rotation in ardabil medical university (iran)

209

Cardiopulmonary resuscitation with a novel chest compression device in a porcine model of cardiac arrest: Improved hemodynamics and mechanisms Original Research Article

210

Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis

211

Cardiopulmonary Resuscitation, Chest Compression Only and Teamwork From the Perspective of Medical Doctors, Surgeons and Anesthesiologists

212

Cardiopulmonary resuscitation, ventilation, defibrillation: In what order?

213

Cardiopulmonary Resuscitation.J.P. Ornato and M.A. Peberdy, Editors, Humana Press (2005) 764 pages, $185 ISBN 1-58829-283-5.

214

Cardiopulmonary resuscitation: Historical perspective to recent investigations

215

Cardiopulmonary resuscitation: Knowledge and personal experience among dentists in Udaipur, India

216

Cardiopulmonary Safety of Propofol Versus Midazolam/Meperidine Sedation for Colonoscopy: A Prospective, Randomized, Double-Blinded Study

217

Cardiopulmonary-Cerebral Resuscitation (CPCR) Training for Nurses in Iran: A Review Study

218

Cardiorenal and sympathetic effects of leptin in spontaneously hypertensive lean and obese koletsky rats

219

Cardiorenal Anemia Syndrome as a Prognosticator for Death in Heart Failure

220

Cardiorenal Effects of Recombinant Human Natriuretic Peptides

221

Cardiorenal Interactions: Insights From the ESCAPE Trial Original Research Article

222

Cardiorenal Outcomes After Slow Continuous Ultrafiltration Therapy in Refractory Patients With Advanced Decompensated Heart Failure

223

Cardio-Renal Profiling with hs-CRP and its Implications as a Diagnostic Tool in Chronic Kidney Disease Patients.

224

Cardiorenal Protective Effects of Year-Long Antihypertensive Therapy With a Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker in Spontaneously Hypertensive Rats

225

Cardiorenal syndrome

226

Cardiorenal Syndrome

227

Cardiorenal Syndrome Review Article

228

Cardiorenal syndrome followed by acute hepatitis C in a patient with acute myeloid leukemia

229

Cardiorenal Syndrome or Renocardiac Syndrome

230

Cardiorenal Syndrome Type 1: Pathophysiological Crosstalk Leading to Combined Heart and Kidney Dysfunction in the Setting of Acutely Decompensated Heart Failure

231

Cardio-renal-anemia syndrome: a report of three cases

232

Cardiorespiratory and all-cause mortality after restrictions on sulphur content of fuel in Hong Kong: an intervention study

233

Cardiorespiratory and neuroendocrine changes induced by methadone in conscious and in isoflurane anaesthetised dogs

234

Cardiorespiratory and thermoregulatory effects of endophyte-infected fescue in exercising horses

235

Cardiorespiratory challenges in Rettʹs syndrome

236

Cardiorespiratory changes during upper gastrointestinal endoscopy

237

Cardio-respiratory control during early development in the model animal zebrafish

238

Cardio-respiratory coupling in untreated patients with major depression

239

CARDIORESPIRATORY CRISIS AT THE END OF PREGNANCY: A CASE OF PHEOCHROMOCYTOMA

240

Cardiorespiratory effects of epidurally administered ketamine or lidocaine in dogs undergoing ovariohysterectomy surgery: a comparative study

241

Cardiorespiratory Fitness and Body Composition of Soccer Referees; Do These Correlate With Proper Performance?

242

Cardiorespiratory fitness and coronary heart disease risk factor association in women

243

Cardiorespiratory Fitness and Its Relationship with Health Risk Factors Among University Students: A Comparison Between Iran and Italy

244

Cardiorespiratory Fitness and Metabolic Risk

245

Cardiorespiratory Fitness and Physical Literacy: Exploring the Nexus. A Scoping Review

246

Cardiorespiratory Fitness and Risk of Nonfatal Cardiovascular Disease in Women and Men With Hypertension

247

Cardiorespiratory fitness and risk of prostate cancer: Findings from the Aerobics Center Longitudinal Study

248

Cardiorespiratory Fitness and the Attenuation of Age-Related Rise in Blood Pressure: An Important Role for Effective Primordial Prevention

249

Cardiorespiratory Fitness as a Correlate of Cardiovascular, Anthropometric, and Physical Risk Factors: Using the Ruffier Test as a Template

250

Cardiorespiratory Fitness as Criterion Validity for Health-Based Metabolic Syndrome Definition in Adolescents

251

Cardiorespiratory Fitness Is Related to the Risk of Sudden Cardiac Death: A Population-Based Follow-Up Study

252

Cardio-respiratory fitness markers among Kenyan university students using a 20m shuttle run test (SRT)

253

Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men

254

Cardiorespiratory Parameters in Intermittent Positive Pressure Ventilation Versus Spontaneous Ventilation in Under One-Year-Old Pediatrics: A Randomized Trial

255

Cardiorespiratory reflexes in a working heart–brainstem preparation of the house musk shrew, Suncus murinus

256

Cardiorespiratory response during exercise in patients with cyanotic congenital heart disease with and without a Fontan operation and in patients with congestive heart failure

257

Cardiorespiratory Response to Exercise After Modified Fontan Operation: Determinants of Performance

258

Cardiorespiratory Response to Exercise After Renal Sympathetic Denervation in Patients With Resistant Hypertension

259

Cardiorespiratory responses to exercise after repair of the univentricular heart

260

Cardiorespiratory Responses to Glittre ADL Test in Bronchiectasis: A Cross-Sectional Study

261

Cardiorespiratory responses to negative pressure ventilation after tetralogy of Fallot repair: hemodynamic tool for patients with low-output state

262

Cardiorespiratory Responses to Table Tennis in Low-Fit Coronary Patients and Implications for Exercise Training

263

Cardiorotective effects of a novel indole derivative with antioxidant properties against ischemic reperfusion injury

264

Cardioscopic guidance of linear lesion creation for radiofrequency ablation

265

Cardioscopic spectrum of the left ventricular endocardial surface and its relation to histologic changes in idiopathic myocarditis

266

CardioSEAL/STARflex versus Amplatzer devices for percutaneous closure of small to moderate (up to 18 mm) atrial septal defects

267

CardioSignal: A database of transcriptional regulation in cardiac development and hypertrophy

268

Cardiosource is a good source for definition of trial acronyms

269

Cardiospermum halicacabum Linn.: Food and Drug

270

Cardiothoracic Surgeons Divided By a Common Language

271

Cardiothoracic surgery in the new millennium: challenges and opportunities in a time of paradox

272

Cardiothoracic Surgery Resident Education: Update on Resident Recruitment and Job Placement

273

Cardiothoracic Surgery, 2nd Edition: by Fritz J. Baumgartner, MD, Georgetown, Texas, Landes Bioscience, 1999, 280 pages, spiral bound, $45, ISBN: 1-570-59559-3

274

Cardiothoracic surgery: a specialty in transition—good to great?

275

Cardiotin localization in mitochondria of cardiomyocytes in vivo and in vitro and its down-regulation during dedifferentiation

276

Cardiotocography and medicolegal issues

277

Cardiotocography in the Prognosis of Perinatal Outcome

278

Cardiotocography only versus cardiotocography plus PR-interval analysis in intrapartum surveillance: a randomised, multicentre trial Original Research Article

279

Cardiotocography only versus cardiotocography plus ST analysis of fetal electrocardiogram for intrapartum fetal monitoring: a Swedish randomised controlled trial

280

Cardiotocography Waveform Analysis Using Image Extraction Technique

281

Cardiotomy Suction: A Major Source of Brain Lipid Emboli During Cardiopulmonary Bypass

282

Cardiotonic activity of methanolic extract of Saussurea lappa Linn roots

283

Cardiotonic Drugs from the Avicenna's Point of View

284

Cardiotonic Modulation in Heart Failure: Insights From Traditional Chinese Medicine

285

Cardiotoxic and Arrhythmogenic Effects of Hemiscorpius lepturus Scorpion Venom in Rats

286

Cardiotoxic Effects of Hemiscorpius Lepturus Scorpion Venom Fractions in Rats

287

Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy

288

Cardiotoxicité de l’association trastuzumab–radiothérapie mammaire : une étude prospective monocentrique

289

Cardiotoxicité de l’association trastuzumab–radiothérapie mammaire : une étude prospective monocentrique

290

Cardiotoxicity associated with sunitinib

291

Cardiotoxicity associated with sunitinib

292

Cardiotoxicity associated with sunitinib – Authorsʹ reply

293

Cardiotoxicity associated with trastuzumab (Herceptin) therapy in the treatment of metastatic breast cancer

294

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

295

Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors

296

Cardiotoxicity of 5-flourouracil: two case reports

297

Cardiotoxicity of cytotoxic drugs

298

Cardiotoxicity of Plants in Iran: a Review

299

Cardiotoxicity of Senna occidentalis in sheep (Ovis aries)

300

Cardiotoxicity Research in Breast Cancer Patients: Past and Future

301

Cardiotoxicity With 5-Fluorouracil Based Agents: Rechallenge Cannot Currently Be Safely Advised

302

Cardiotoxicity with adjuvant trastuzumab use in breast cancer: A single institution’s experience

303

Cardiotrophin-1 in Patients with Acute Myocardial Infarction

304

Cardiotrophin-1 Induces Heat Shock Protein Accumulation in Cultured Cardiac Cells and Protects them from Stressful Stimuli

305

Cardiotrophin-1 induces proliferation and activation of primary adult rat cardiac fibroblasts

306

Cardiotrophin-1 is a prophylactic against the development of chronic hypoxic pulmonary hypertension in rats

307

Cardiotrophin-1 Phosphorylates Akt and BAD, and Prolongs Cell Survival via a PI3K-dependent Pathway in Cardiac Myocytes

308

Cardiotrophin-1 regulates osteoclast and osteoblast function in a manner distinct from other gp130 cytokines

309

Cardiovacular and cerebrovacular mortality aociated with ocular peudoexfoliation

310

Cardiovacular Dieae, it Rik Factor and Treatment, and Age-related Macular Degeneration: Women’ Health Initiative ight Exam Ancillary tudy

311

Cardiovacular Dieae, it Rik Factor and Treatment, and Age-related Macular Degeneration: Women’ Health Initiative ight Exam Ancillary tudy Original Reearch Article

312

Cardiovacular Rik Factor and Age-related Macular Degeneration: The Lo Angele Latino Eye tudy Original Reearch Article

313

Cardiovascular Abnormalities in Cirrhosis: the Possible Mechanisms

314

Cardiovascular Abnormalities in Hyperthyroidism

315

Cardiovascular Abnormalities in Hyperthyroidism

316

Cardiovascular abnormalities in hyperthyroidism

317

Cardiovascular abnormalities in hyperthyroidism: A prospective Doppler echocardiographic study

318

Cardiovascular abnormalities in never-treated hypertensives according to nondipper status

319

Cardiovascular Abnormalities in Sickle Cell Disease

320

Cardiovascular activity and the antibody response to vaccination

321

Cardiovascular adaptations to endurance training and detraining in young and older athletes

322

Cardiovascular aging and psychometric performances: correlations in a group of ultraseptagenarian elderly

323

Cardiovascular Aging: What We Can Learn From Caloric Restriction

324

Cardiovascular and Antioxidant Effects of the Methanol Extract From the Stem Bark of Erythrina Senegalensis DC (Fabaceae)

325

Cardiovascular and autonomic nervous functions during acclimatization to hypoxia in conscious rats

326

Cardiovascular and behavioural components of conditioned fear to context after ganglionic and α-adrenergic blockade

327

Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT)

328

Cardiovascular and Cancer Mortality in Very Elderly Post-Myocardial Infarction Patients Receiving Statin Treatment

329

Cardiovascular and endocrine responses to cutaneous electrical stimulation after fentanyl in the ovine fetus

330

Cardiovascular and metabolic effects of the vasopeptidase inhibitor, omapatrilat in spontaneously hypertensive rats

331

Cardiovascular and metabolic responses to two receptor-selective opioid agonists in pregnant sheep

332

Cardiovascular and Metabolic Risk Factors: How Can We Improve Outcomes in the High-Risk Patient?

333

Cardiovascular and mortality risk prediction and stratification using urinary albumin excretion in older adults ages 68–102: The cardiovascular Health Study

334

Cardiovascular and muscle activity during chewing in whiplash-associated disorders (WAD)

335

Cardiovascular and psychosomatic symptoms among relatives of patients waiting for possible coronary revascularization

336

Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review

337

Cardiovascular and renal disease in the adolescent guinea pig after chronic placental insufficiency

338

Cardiovascular and renal effects of a collagen cross-link breaker (ALT 711) in adult and aged spontaneously hypertensive rats

339

Cardiovascular and Renal Effects of Hibiscus Sabdariffa Linnaeus. in Patients with Diabetic Nephropathy: A Randomized, Double-Blind, Controlled Trial

340

Cardiovascular and renal events in uncomplicated mild hypertensive patients with sustained and white coat hypertension

341

Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture

342

Cardiovascular and Respiratory Effects of Romifidine and/or Xylazine in Ketamine Anaesthesia in Dog: An Experimental Study

343

Cardiovascular and respiratory emergency dispatch due to shortterm exposure to ambient PM10 in Dezful, Iran

344

Cardiovascular and respiratory response to ascent of the Damavand summit by classic method in elite climbers

345

Cardiovascular and Systemic MicrovascularEffects of Anti-Vascular Endothelial Growth Factor Therapy for Cancer

346

Cardiovascular and ventilatory control during exercise in chronic heart failure: Role of muscle reflexes

347

Cardiovascular anomalies associated with chromosome 22q11.2 deletion

348

Cardiovascular Anomalies Associated With Chromosome 22q11.2 Deletion Syndrome

349

Cardiovascular anomalies in patients with chromosome 22q11.2 deletion: A Korean multicenter study

350

Cardiovascular applications for artifical structural proteins produced by recombinant technologies

351

Cardiovascular autonomic dysfunction correlates with brain MRI lesion load in MS

352

Cardiovascular Autonomic Dysfunction in Patients of Nonalcoholic Fatty Liver Disease

353

Cardiovascular autonomic function in healthy adolescents

354

Cardiovascular autonomic function testing in asymptomatic T. cruzi carriers: a sensitive method to identify subclinical Chagasʹ disease

355

Cardiovascular autonomic function tests in type 2 diabetes mellitus with micro albuminuria

356

Cardiovascular autonomic modulation by nitric oxide synthases accounts for the augmented enalapril-evoked hypotension in ethanol-fed female rats

357

Cardiovascular autonomic nervous response to postural change in 610 healthy Japanese subjects in relation to age

358

Cardiovascular autonomic neuropathy in rheumatoid arthritis assessed by cardiovascular autonomic function tests: A cross-sectional survey

359

Cardiovascular autonomic regulation in Non-Obese Diabetic (NOD) mice

360

Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes

361

Cardiovascular benefits of nuts

362

Cardiovascular Care Facts: A Report From the National Cardiovascular Data Registry: 2011

363

Cardiovascular cavitation

364

Cardiovascular changes during induced emotion: An application of langʹs theory of emotional imagery

365

Cardiovascular changes in response to ovarian stimulation

366

Cardiovascular Characteristics in American Youth With Prehypertension

367

Cardiovascular characterization of Pkd2+/LacZ mice, an animal model for the autosomal dominant polycystic kidney disease type 2 (ADPKD2)

368

Cardiovascular complications and acute ischemic stroke after the treatment with epinephrine in an anaphylactic patient

369

Cardiovascular Complications in Infants of Diabetic Mothers: An Observational Study in a Pediatric Cardiology Clinic in Tehran

370

Cardiovascular Complications in Obstructive Sleep Apnea Syndrome

371

Cardiovascular complications in patients with megaesophagus due to Chagas disease undergoing the Serra-Dَria operation

372

Cardiovascular Complications of Cancer Therapy: Incidence, Pathogenesis, Diagnosis, and Management

373

Cardiovascular Complications of Chronic Opium Consumption: A Narrative Review Article

374

Cardiovascular Complications of COVID-19 in Patients With Multiple Sclerosis: A Lesson From Our Experience

375

Cardiovascular Complications of Direct Laryngoscopy vs Video Laryngoscopy in Patients over 65 Years Old

376

Cardiovascular complications of malignant carcinoid disease, ,

377

Cardiovascular Complications of Radiotherapy

378

Cardiovascular Complications of the Guillain-Barré Syndrome

379

Cardiovascular Conditions in Patients With Aluminum Phosphide Poisoning

380

Cardiovascular consequences of laparoscopic surgery

381

Cardiovascular consequences of sleep apnea: I -Epidemiology

382

Cardiovascular consequences of sleep apnea: II-Cardiovascular mechanisms

383

Cardiovascular consequences of sleep apnea: III-Impact of continuous positive airway pressure treatment

384

Cardiovascular Considerations in Antidepressant Therapy: An Evidence-Based Review

385

Cardiovascular control and plasma catecholamines during rest and mental stress: effects of posture

386

Cardiovascular control in Antarctic fish

387

Cardiovascular data on sildenafil citrate: Introduction

388

Cardiovascular Death and Cancer Death—Competing Risk?

389

Cardiovascular death from panic disorder and panic-like anxiety: A critical review of the literature

390

Cardiovascular determinants of plasma fibronectin in an elderly population: The EVA study

391

Cardiovascular disease

392

Cardiovascular Disease Among International Travellers

393

Cardiovascular disease among Mexican Americans

394

Cardiovascular disease and bone

395

Cardiovascular disease and chronic kidney disease: Insights and an update

396

Cardiovascular disease and cognitive performance in middle-aged and elderly men

397

Cardiovascular disease and mortality in statin-treated patients with familial hypercholesterolemia

398

Cardiovascular disease and neoplasms after pancreas transplantation

399

Cardiovascular disease and neoplasms after pancreas transplantation

400

Cardiovascular disease and neoplasms after pancreas transplantation

401

Cardiovascular Disease and Olympic Games in China

402

Cardiovascular disease and risk factors among 345 adults in rural India—the Andhra Pradesh Rural Health Initiative

403

Cardiovascular disease and risk factors in adults with hypopituitarism

404

Cardiovascular disease and risk factors in Montana American Indians and non-Indians Original Research Article

405

Cardiovascular disease and risk factors in patients with type 2 diabetes mellitus in Mashhad, Islamic Republic of Iran

406

Cardiovascular Disease and Risk in Primary Care Settings in the United States

407

Cardiovascular disease and sexual functioning

408

Cardiovascular disease and sleep-related erections

409

Cardiovascular disease and the global tobacco epidemic: a wake-up call for cardiologists

410

Cardiovascular disease burden shifts

411

Cardiovascular disease detection using bio-sensing techniques

412

Cardiovascular disease events and its predictors in women: Isfahan Cohort Study (ICS)

413

Cardiovascular Disease in Adult and Pediatric HIV/AIDS

414

Cardiovascular disease in arsenic-exposed subjects living in the arseniasis-hyperendemic areas in Taiwan

415

Cardiovascular Disease in Asian Americans: Unmasking Heterogeneity

416

Cardiovascular disease in Chinese type 2 diabetic women is associated with a prolonged QTc interval

417

Cardiovascular Disease in Chronic Renal Failure Patients

418

Cardiovascular disease in familial hypercholesterolaemia: Influence of low-density lipoprotein receptor mutation type and classic risk factors

419

Cardiovascular disease in Hajj pilgrims

420

Cardiovascular disease in HIV infection

421

Cardiovascular Disease in Iran in the Last 40 Years: Prevalence, Mortality, Morbidity, Challenges and Strategies for Cardiovascular Prevention

422

Cardiovascular disease in Latin America

423

Cardiovascular disease in lupus patients: Should all patients be treated with statins and aspirin?

424

Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria Original Research Article

425

Cardiovascular disease in older people

426

Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Saskatchewan Canada: Cardiovascular Disease in COPD Patients

427

Cardiovascular disease in patients with chronic renal failure

428

Cardiovascular disease in patients with end-stage renal disease on hemodialysis in a developing country

429

Cardiovascular disease in persons with depressive and anxiety disorders

430

Cardiovascular disease in postmenopausal women: myths and reality

431

Cardiovascular disease in rheumatoid arthritis

432

Cardiovascular disease in South Asians

433

Cardiovascular disease in South Asians

434

Cardiovascular Disease in the Developing World: Prevalences, Patterns, and the Potential of Early Disease Detection

435

Cardiovascular disease in the NHANES III

436

Cardiovascular disease in the polycystic ovary syndrome: New insights and perspectives

437

Cardiovascular disease in the tropics, ethics, and need for action

438

Cardiovascular Disease Knowledge among Cardiac Rehabilitation Patients in Eastern Iran: A Cross-Sectional Study

439

Cardiovascular disease knowledge among culturally Deaf patients in Chicago

440

Cardiovascular Disease Mortality and Years of Life Lost Attributable to Non-optimal Systolic Blood Pressure and Hypertension in Northeastern Iran

441

Cardiovascular Disease Mortality in Asian Americans

442

Cardiovascular Disease Mortality in Hispanics and Non-Hispanic Whites

443

Cardiovascular Disease Patient's Quality of Life in Tabriz City in Iran in 2018

444

Cardiovascular Disease Prevention among Youth: Visioning the Future

445

Cardiovascular Disease Prevention for Women Attending Breast and Cervical Cancer Screening Programs: The WISEWOMAN Projects

446

Cardiovascular Disease Prevention in Eastern Europe

447

Cardiovascular disease prevention in Russia: Challenges and opportunities

448

Cardiovascular Disease Prevention Research at the National Heart, Lung, and Blood Institute

449

Cardiovascular Disease Prevention Using Fixed Dose Pharmacotherapy in Iran: Updated Meta-Analyses and Mortality Estimation

450

Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis

451

Cardiovascular Disease Risk Assessment: Triglyceride/High-Density Lipoprotein versus Metabolic Syndrome Criteria

452

Cardiovascular Disease Risk Factor Intervention in Low-Income Women: The North Carolina WISEWOMAN Project

453

Cardiovascular Disease Risk Factors

454

Cardiovascular Disease Risk Factors among Migrant Seasonal Agricultural Workers: Comparison with Local Residents

455

Cardiovascular Disease Risk Factors and Cardiac Markers among Male Cement Workers in Calabar, Nigeria

456

Cardiovascular Disease Risk Factors and Cognitive Impairment

457

Cardiovascular disease risk factors in 2 distinct ethnic groups: Indian and Pakistani compared with American premenopausal women

458

Cardiovascular disease risk factors in 6–7-year-old Danish children: the Copenhagen School Child Intervention Study

459

Cardiovascular Disease risk Factors in Male Cigarette Smokers in Calabar, Southern Nigeria

460

Cardiovascular Disease Risk Factors in Patients with Confirmed Cardiovascular Disease

461

Cardiovascular Disease Risk Factors Profile in Individuals With Diabetes Compared With Non-Diabetic Subjects in North-East of Iran

462

Cardiovascular disease risk factors, metabolic syndrome and obesity in an Iranian population

463

Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies

464

Cardiovascular disease risk prediction among Iranian patients with diabetes mellitus in Isfahan Province, Iran, in 2014, by using Framingham risk score, atherosclerotic cardiovascular disease risk score, and high-sensitive C-reactive protein

465

Cardiovascular disease risk profile among young Saudi women of Al-Qassim, Saudi Arabia: A cross-sectional study

466

Cardiovascular disease risk reduction in the Behavioral Risk Factor Surveillance System Original Research Article

467

Cardiovascular Disease Risk Stratification With Stress Single-Photon Emission Computed Tomography Technetium-99m Tetrofosmin Imaging in Patients With the Metabolic Syndrome and Diabetes Mellitus

468

Cardiovascular disease risks in adolescent males

469

Cardiovascular disease, chronopharmacotherapy, and the molecular clock

470

Cardiovascular disease, fibrinogen and the acute phase response: Associations with lipids and blood pressure in patients with chronic renal disease Original Research Article

471

Cardiovascular disease—risk benefits of clean fuel technology and policy: A statistical analysis

472

Cardiovascular diseases (CVD) risk factors, physical activity (PA) and plasma plasminogen (Plg) in a random sample of community-dwelling elderly

473

Cardiovascular Diseases and Risk Factors in Finland

474

Cardiovascular Diseases before and after Renal Transplantation

475

Cardiovascular diseases do not influence the mental health outcome of older men with depression over 6 years

476

Cardiovascular diseases in Latin America and the Caribbean

477

Cardiovascular Diseases in Natural Disasters; a Systematic Review

478

Cardiovascular diseases in the mirror of science

479

Cardiovascular diseases, health status, brain imaging findings and neuropsychological functioning in neurologically healthy elderly individuals

480

Cardiovascular Disorders in the Context of Non-Alcoholic Fatty Liver Disease: A Literature Review

481

Cardiovascular Disorders Risk Factors in Different Industries of Iran

482

Cardiovascular distribution of the calcium sensing receptor before and after burns

483

Cardiovascular Disturbances in Workers Exposed to Carbon Disulfide

484

Cardiovascular drug delivery with ultrasound and microbubbles

485

Cardiovascular Drug Interactions of Diclofenac and Dobutamine

486

Cardiovascular Dual Source Computed Tomography for Aortic Coarctation in a Neonate: One-Second Scan With Ultra-Low Radiation Dose

487

Cardiovascular dynamics and dimensions after bicaval and standard cardiac transplantation

488

Cardiovascular dysautonomia in Parkinsonʹs disease with visual hallucinations

489

Cardiovascular Effect of Bans on Smoking in Public Places

490

Cardiovascular Effect of Bans on Smoking in Public Places: A Systematic Review and Meta-Analysis

491

Cardiovascular Effect of Cuneiform Nucleus During Hemorrhagic Hypotension

492

Cardiovascular Effect of Dorsal Periaqueductal Gray During Lipopolysaccharide-induced Hypotension

493

Cardiovascular effect of preeclampsia upon offspring development: Are (Pro) renin-renin receptor ((P)RR) and gender related?

494

Cardiovascular effects of 6 months of hormone replacement therapy versus placebo: differences associated with years since menopause

495

Cardiovascular Effects of a Trandolapril/Verapamil Combination in Patients With Mild to Moderate Essential Hypertension

496

Cardiovascular effects of a μ-selective opioid agonist (tyrosine-D-arginine-phenylalanine-lysine-NH2) in fetal sheep: Sites and mechanisms of action, ,

497

Cardiovascular Effects of Acute Organophosphate Poisoning

498

Cardiovascular effects of Adonis aestivalis in anesthetized sheep

499

Cardiovascular Effects of Aldosterone and Post–Acute Myocardial Infarction Pathophysiology

500

Cardiovascular Effects of Allium Sativum (Garlic): An Evidence-Based Review

501

Cardiovascular Effects of Androgenic Anabolic Steroids in Male Bodybuilders Determined by Tissue Doppler Imaging

502

Cardiovascular Effects of Antidepressants and Mood Stabilizers

503

Cardiovascular effects of breast cancer radiotherapy

504

Cardiovascular effects of caffeine in men and women

505

Cardiovascular Effects of Carbamazepine Toxicity, ,

506

Cardiovascular effects of carbon monoxide and cigarette smoking

507

Cardiovascular Effects of Carbon Monoxide Poisoning

508

Cardiovascular effects of centrally applied endothelin-11–31 and its relationship to endothelin-11–21 in rats

509

Cardiovascular Effects of Circular Training (Resistance-Interval) Combined with Berberine on Overweight Elderly Men

510

Cardiovascular effects of Danshen

511

Cardiovascular effects of estrogen

512

Cardiovascular Effects of Exercise: Role of Endothelial Shear Stress

513

Cardiovascular effects of fingolimod: A review article.

514

Cardiovascular effects of French horn playing

515

Cardiovascular Effects of Hyperhomocysteinemia in Conscious Unrestrained Rats

516

Cardiovascular effects of induced hypothermia after lung transplantation

517

Cardiovascular effects of inhaled nitric oxide in a canine model of cardiomyopathy

518

Cardiovascular effects of inhaled nitric oxide in a canine model of cardiomyopathy

519

Cardiovascular effects of intravaginal misoprostol in the mid trimester of pregnancy

520

Cardiovascular effects of milk enriched with ω-3 polyunsaturated fatty acids, oleic acid, folic acid, and vitamins E and B6 in volunteers with mild hyperlipidemia

521

Cardiovascular Effects of Mixed Amphetamine Salts Extended Release in the Treatment of School-Aged Children with Attention-Deficit/Hyperactivity Disorder

522

Cardiovascular effects of nitrergic system of the pedunculopon-tine tegmental nucleus in anesthetized rats

523

Cardiovascular Effects of Olive, a Qur’anic Fruit: a Systematic Review

524

Cardiovascular effects of prolonged milrinone inhalation inpatients with pulmonary hypertension undergoing mitral valvereplacement

525

Cardiovascular effects of propranolol in normal and stressed female and male rats assessed by traditional and nonlinear dynamics methods

526

Cardiovascular effects of raloxifene: the arterial and venous systems

527

Cardiovascular Effects of Saffron: An Evidence-Based Review

528

Cardiovascular effects of sex hormones

529

Cardiovascular effects of sildenafil citrate and recommendations for its use

530

Cardiovascular effects of standardized hydroalcoholic extract of Ribes khorasanicum fruit in acute hypertensive rats

531

Cardiovascular effects of systemic cancer treatment

532

Cardiovascular effects of tadalafil

533

Cardiovascular effects of tadalafil in patients on common antihypertensive therapies

534

Cardiovascular effects of transdermal nicotine in mildly hypertensive smokers

535

Cardiovascular effects of two amides (Piperine and Piperdardine) isolated from Piper tuberculatum Jacq.

536

Cardiovascular Emergencies in Cruise Ship Passengers

537

Cardiovascular endocrinology springs surprises

538

Cardiovascular Event Rates in Diabetic and Nondiabetic Individuals With and Without Established Atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)

539

Cardiovascular Event Reduction and Adverse Events Among Subjects Attaining Low-Density Lipoprotein Cholesterol <50 mg/dl With Rosuvastatin: The JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvast

540

Cardiovascular event risk in relation to arterial stiffness in patients with subclinical peripheral atherosclerosis

541

Cardiovascular Event Risk: High-Density Lipoprotein and Paraoxonase

542

Cardiovascular Events and Football Tournaments

543

Cardiovascular Events and Mortality in Newly and Chronically Depressed Persons >70 Years of Age

544

Cardiovascular events and plasma atrial natriuretic peptide level in patients with hypertrophic cardiomyopathy

545

Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial

546

Cardiovascular Events During Differing Hypertension Therapies in Patients With Diabetes

547

Cardiovascular events during initial antihypertensive therapy with either a calcium antagonist or a diuretic/beta-blocker: meta-analysis of 7 clinical trials

548

Cardiovascular Events in Patients With Coronary Plaque Rupture and Nonsignificant Stenosis

549

Cardiovascular Events in Patients With Fabry Disease: Natural History Data From the Fabry Registry

550

Cardiovascular Events in People With Type 2 Diabetes: Performance of Framingham, UKPDS, and ADVANCE Risk Equations

551

Cardiovascular Events in the 1996 Olympic Games

552

Cardiovascular Factors and Cognitive Impairment: A Role for Unsaturated Fatty Acids and Mediterranean Diet?

553

Cardiovascular Features of Heart Failure With Preserved Ejection Fraction Versus Nonfailing Hypertensive Left Ventricular Hypertrophy in the Urban Baltimore Community: The Role of Atrial Remodeling/Dysfunction Original Research Article

554

Cardiovascular findings in patients with psoriasis.

555

Cardiovascular fitness and neurocognitive function in older Adults: a brief review

556

Cardiovascular Function and Predictors of Exercise Capacity in Patients With Colorectal Cancer

557

Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice

558

Cardiovascular gene delivery: The good road is awaiting

559

Cardiovascular gene therapy Review Article

560

Cardiovascular Gene Therapy: Advances and Challenges

561

Cardiovascular Genetics, Genomics, and Proteomics

562

Cardiovascular genomics

563

Cardiovascular Genomics: Estimating the Total Number of Genes Expressed in the Human Cardiovascular System

564

Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study

565

Cardiovascular Health among Adults in Syria: A Model from Developing Countries

566

Cardiovascular health and economic effects of smoke-free workplaces

567

Cardiovascular health and economic effects of smoke-free workplaces: Am J Med. 2004;117:32-38

568

Cardiovascular Health Awareness Program (CHAP): A community cluster-randomised trial among elderly Canadians

569

CARDIOVASCULAR HEALTH EDUCATION OF FAMILIES: THE IMPORTANCE OF SCHOOL-BASED PREVENTION STRATEGIES

570

Cardiovascular Health in Europe: A Global Problem

571

Cardiovascular Health in Men Attending for Abdominal Aortic Aneurysm Screening

572

Cardiovascular hybrid drugs: new benzazepinone derivatives as bradycardic agents endowed with selective β1-Non-competitive antagonism Original Research Article

573

Cardiovascular imaging

574

Cardiovascular Imaging in Thalassemia: An Issue With Limited Data

575

Cardiovascular Imaging in the Management of Atrial Fibrillation Review Article

576

Cardiovascular implications of the factor V Leiden mutation

577

Cardiovascular Interventions in Clinical Practice

578

Cardiovascular Inventiveness Within the University of Minnesota Department of Surgery

579

cardiovascular involvement in blood cancers: all, aml, cll, and cml

580

Cardiovascular Involvement in Children with Osteogenesis Imperfecta

581

Cardiovascular involvement in patients with systemic sclerosis: insights from electromechanical characteristics of the heart

582

Cardiovascular involvement in systemic autoimmune diseases

583

Cardiovascular Issues in Hypogonadism and Testosterone Therapy

584

Cardiovascular Magnetic Resonance Determinants of Left Ventricular Noncompaction

585

Cardiovascular magnetic resonance findings in typical versus atypical forms of the acute apical ballooning syndrome (Takotsubo cardiomyopathy)

586

Cardiovascular Magnetic Resonance for Risk Stratification of Arrhythmia in Hypertrophic Cardiomyopathy

587

Cardiovascular magnetic resonance for the assessment of pulmonary arterial hypertension: toward a comprehensive CMR exam

588

Cardiovascular Magnetic Resonance for the Diagnosis of Acute Myocarditis: Prospects for Detecting Myocardial Inflammation

589

Cardiovascular magnetic resonance imaging demonstrates mitral valve endocarditis

590

Cardiovascular magnetic resonance imaging: Current and emerging applications Review Article

591

Cardiovascular Magnetic Resonance in Arrhythmogenic Right Ventricular Cardiomyopathy Revisited: Comparison With Task Force Criteria and Genotype Original Research Article

592

Cardiovascular Magnetic Resonance in Clinically Suspected Cardiac Amyloidosis: Diagnostic Value of a Typical Pattern of Late Gadolinium Enhancement

593

Cardiovascular Magnetic Resonance in Clinically Suspected Cardiac Amyloidosis: Noninvasive Imaging Compared to Endomyocardial Biopsy Original Research Article

594

Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper

595

Cardiovascular Magnetic Resonance in Patients With Myocardial Infarction: Current and Emerging Applications

596

Cardiovascular Magnetic Resonance in Predicting the Reduction in Pulmonary Artery Pressure in Patients With Mitral Stenosis After Surgical or Interventional Treatment

597

Cardiovascular magnetic resonance in the follow-up of patients with corrected tetralogy of Fallot: A review

598

Cardiovascular magnetic resonance of asymptomatic myocardial infarction

599

Cardiovascular magnetic resonance of iatrogenic ventricular scarring due to catheter ablation for left ventricular tachycardia

600

Cardiovascular Magnetic Resonance of imminent cardiac tamponade due to postpericardiotomy syndrome

601

Cardiovascular magnetic resonance ofacute myocardial infarction at a very early stage

602

Cardiovascular Magnetic Resonance Perfusion Imaging at 3-Tesla for the Detection of Coronary Artery Disease: A Comparison With 1.5-Tesla Original Research Article

603

Cardiovascular magnetic resonance signs of ischemia in hypertrophic cardiomyopathy

604

Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy Original Research Article

605

Cardiovascular Magnetic Resonance: Warren J. Manning and Dudley J. Pennell, London, UK, Churchill Livingstone 2002, 506 pages, 367 illustrations, US$120.00

606

Cardiovascular Malformations in Congenital Rubella Syndrome: A Case Report

607

Cardiovascular malformations in Fryns Syndrome

608

Cardiovascular Malformations in Infants of Diabetic Mothers: A Retrospective Case-Control Study

609

Cardiovascular Manifestation of a Family with Marfan’s Syndrome

610

Cardiovascular manifestations associated with influenza virus infection

611

Cardiovascular manifestations in COVID-19 patients: A systematic review and meta-analysis

612

Cardiovascular Manifestations in Human Immunodeficiency Virus-Infected Patients

613

Cardiovascular manifestations of anabolic steroids in association with demographic variables in body building athletes

614

Cardiovascular Manifestations of Carbon Monoxide Poisoning

615

Cardiovascular Manifestations of Hyperthyroidism Before and After Antithyroid Therapy: A Matched Case-Control Study Original Research Article

616

Cardiovascular Manifestations of Moderate to Severe Carbon Monoxide Poisoning Original Research Article

617

Cardiovascular manifestations of pheochromocytoma

618

Cardiovascular Medications and Risk of Cancer

619

Cardiovascular medicine update

620

Cardiovascular monitoring advised during growth hormone therapy

621

Cardiovascular Morbidity and Mortality in Community-Dwelling Elderly Individuals With Calcification of the Fibrous Skeleton of the Base of the Heart and Aortosclerosis (The Cardiovascular Health Study)

622

Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End point reduction in hypertension (LIFE) study Original Research Article

623

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

624

Cardiovascular Morbidity and Mortality in Rheumatoid Arthritis

625

Cardiovascular Morbidity and Mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in Chronic Renal Failure: A Multicenter, Randomized, Controlled Trial Original Research Article

626

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

627

Cardiovascular Morphing

628

Cardiovascular Mortality and Heart Failure Risk Score for Patients After ST-Segment Elevation Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (Data from the Leiden MISSION! Infarct Registry)

629

Cardiovascular mortality focusing on socio-economic influence: The low-risk population of Halland compared to the population of Sweden as a whole

630

Cardiovascular Mortality in Chronic Kidney Disease Patients Undergoing Percutaneous Coronary Intervention Is Mainly Related to Impaired P2Y12 Inhibition by Clopidogrel

631

Cardiovascular Mortality in High-Risk Patients and T-786C Polymorphism in Promoter Region of the Endothelial Nitric Oxide Synthase Gene

632

Cardiovascular mortality in New York City after September 11, 2001

633

Cardiovascular mortality in patients followed up for diabetic foot

634

Cardiovascular Mortality of Turkish Nationals Residing in West Germany

635

Cardiovascular neurons of the rat brain express extracellular calcium-sensing receptors

636

Cardiovascular operations in patients with dialysis-dependent renal failure

637

Cardiovascular outcome in hospitalized patients with minimal troponin I elevation and normal creatine phosphokinase

638

Cardiovascular Outcome in Relation to Progression to Hypertension in the Copenhagen MONICA Cohort

639

Cardiovascular Outcome in Treated Hypertensive Patients with Responder, Masked, False Resistant, and True Resistant Hypertension

640

Cardiovascular outcome of patients with abnormal coronary vasomotion and normal coronary arteriography is worse in type 2 diabetes mellitus than in arterial hypertension: A 10 year follow-up study

641

Cardiovascular Outcomes in Male Veterans With Rheumatoid Arthritis

642

Cardiovascular Outcomes in Randomized Trials: Should Time to First Event for “Hard” End Points Remain the Standard Approach?

643

Cardiovascular Outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management): An Assessment of Individual Antiarrhythmic Drug Therapies Compared With Rate Control With Propensity Score-Matched Analyses

644

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison

645

Cardiovascular Pathology A platform for research, teaching, and clinical care

646

Cardiovascular pathology at the crossroads: the dilemma of cardiac pathologists

647

Cardiovascular pathology in the land of doges

648

Cardiovascular Pathology: a new journal for an old need

649

Cardiovascular pathology: Clinicopathological correlations and pathogenetic mechanisms : Schoen FJ, Gimbrone MA (editors) Williams and Wilkins, Georgia, USA; 229 pp.; £67.00; ISBN 0-683-07600-0

650

Cardiovascular Pathology: From whence we came … to where we are going

651

Cardiovascular pathology: maturation of a discipline and the Society for Cardiovascular Pathology

652

Cardiovascular patients’ experiences of living with pacemaker: Qualitative study

653

Cardiovascular pharmacology of nonselective nonsteroidal anti-inflammatory drugs and coxibs: clinical considerations

654

Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction

655

Cardiovascular Phenotype in HFpEF Patients With or Without Diabetes: A RELAX Trial Ancillary Study

656

Cardiovascular Preventing Effects of Dipeptidyl Peptidase-4 Inhibitors: Beyond Glucagon-Like Peptide-1

657

Cardiovascular Prevention in Asymptomatic Diabetic Patients

658

Cardiovascular Prevention in Diabetes Mellitus: No Magic Remedies

659

Cardiovascular prevention in the Hartslag Limburg project: Effects of a high-risk approach on behavioral risk factors in a general practice population

660

Cardiovascular professionalism and ethics in the modern era Review Article

661

Cardiovascular profile of loratadine

662

Cardiovascular prognosis in relation to apolipoproteins and other lipid parameters in patients with stable angina pectoris treated with verapamil or metoprolol: Results from the Angina Prognosis Study in Stockholm (APSIS) Original Research Article

663

Cardiovascular prognostic value of vascular involvement in Behcetʹs disease

664

Cardiovascular Property of Resistance Training With an Emphasis on PI3K/AKT1 Genes Expression in Type 2 Diabetic Rats

665

Cardiovascular protection and blood pressure reduction: a meta-analysis

666

Cardiovascular protection in haemophilia

667

Cardiovascular protection of deep-seawater drinking water in high-fat/cholesterol fed hamsters

668

Cardiovascular protection of nonmitogenic human acidic fibroblast growth factor from oxidative damage in vitro and in vivo

669

Cardiovascular Protection Using Beta-Blockers: A Critical Review of the Evidence Review Article

670

Cardiovascular protective effect of darbepoetin-α: A long-acting erythropoietic analogue

671

Cardiovascular proteomic analysis

672

Cardiovascular Proteomics: Tools to Develop Novel Biomarkers and Potential Applications Review Article

673

Cardiovascular reactivity and hostility: The dynamic cerebral laterality effect

674

Cardiovascular reactivity, affective responses and performance related to the risk dimensions of coronary-prone behaviour

675

Cardiovascular recovery from laboratory stress: Biopsychosocial concomitants in older adults

676

Cardiovascular regulation by -atginine in the brain of rats : Role of the brain renin-angiotensin system and nitric oxide

677

CARDIOVASCULAR REGULATION IN TGR(mREN2)27 RATS: 24h VARIATION IN PLASMA CATECHOLAMINES, ANGIOTENSIN PEPTIDES, AND TELEMETRIC HEART RATE VARIABILITY

678

Cardiovascular remodeling after AVF surgery in rats assessed by a clinical MRI scanner

679

Cardiovascular remodeling and arterial hypertension in rheumatoid arthritis: Predisposing conditions and risk factors

680

Cardiovascular remodeling is greater in isolated systolic hypertension than in diastolic hypertension in older adults: the Insufficienza Cardiaca negli Anziani Residenti (ICARE) a Dicomano Study

681

Cardiovascular remodeling, apoptosis, and drugs

682

Cardiovascular research in Spain. A comparative scientometric study

683

Cardiovascular response to sexual activity

684

Cardiovascular responses across stressor phases: The match of gender and gender-role identification with the gender relevance of the stressor

685

Cardiovascular Responses during Head-Down Crooked Kneeling Position Assumed in Muslim Prayers

686

Cardiovascular responses evoked by mild cool stimuli in primary Raynauds disease: the role of endothelin

687

Cardiovascular responses in humans to experimental chewing of gums of different consistencies

688

Cardiovascular responses in patients with acute allergic reactions treated with parenteral epinephrine

689

Cardiovascular responses induced by Catalase Inhibitior into the Fourth Cerebral Ventricle is changed in Wistar rats exposed to sidestream cigarette smoke

690

Cardiovascular responses of perimenopausal women to hormonal replacement therapy, ,

691

Cardiovascular responses of physically active colligate subjects during normal and warm conditions, and determination of sweat rates

692

Cardiovascular responses produced by resistin injected into paraventricular nucleus mediated by the glutamatergic and CRFergic transmissions within rostral ventrolateral medulla

693

Cardiovascular responses to agency and communion stressors in young women

694

Cardiovascular responses to aquatic walking in middle-aged and elderly persons with physical disabilities

695

Cardiovascular responses to chemoreflex activation with potassium cyanide or hypoxic hypoxia in awake rats

696

Cardiovascular responses to clonidine in alcohol withdrawal: are they related to psychopathology and mental well-being?

697

Cardiovascular responses to dynamic submaximal exercise in children previously treated with anthracycline

698

Cardiovascular responses to electrical stimulation of sympathetic nerves in the pithed mouse

699

Cardiovascular responses to exercise in children and adolescents with myocardial dysfunction

700

Cardiovascular responses to laughter: A pilot project

701

Cardiovascular responses to microinjection of AMPA into the rostral commissural nucleus tractus solitarius of awake rats

702

CARDIOVASCULAR RESPONSES TO OROTRACHEAL INTUBATION IN PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFTING SURGERY (Comparing Fiberoptic Bronchoscopy With Direct Laryngoscopy)

703

CARDIOVASCULAR RESPONSES TO SCALP INFILTRATION, USING ADRENALINE, WITH OR WITHOUT LIGNOCAINE, DURING CRANIOTOMY

704

Cardiovascular responses to sciatic nerve stimulation are blocked by paratrigeminal nucleus lesion

705

Cardiovascular responses to the injection of L-glutamate in the lateral hypothalamus of unanesthetized or anesthetized rats

706

Cardiovascular Responses to Tonic Pain in REM Sleep-Deprived Rats Role of Melatonin and Beta Endorphin

707

Cardiovascular Risk After Bariatric Surgery for Obesity

708

Cardiovascular Risk Among Adults With Chronic Kidney Disease, With or Without Prior Myocardial Infarction Original Research Article

709

Cardiovascular Risk Among Men Seeking Help for Erectile Dysfunction

710

Cardiovascular risk and atherosclerosis prevention

711

Cardiovascular risk and blood pressure reduction: an overview of the outcome trials

712

Cardiovascular risk and sildenafil

713

Cardiovascular risk assessment

714

Cardiovascular risk assessment

715

Cardiovascular risk assessment in HIV-infected patients attending a designated lipid clinic

716

Cardiovascular Risk Assessment of Liver Transplantation Candidates

717

Cardiovascular Risk Assessment of Pulmonary Embolism With the GRACE Risk Score

718

Cardiovascular Risk Assessment of the Liver Transplant Candidate

719

Cardiovascular risk associated with hormone replacement therapy: some critical questions about the type of estrogen used in most clinical trials

720

Cardiovascular risk changes after lipid lowering medications: are they predictable?

721

Cardiovascular risk continuum: implications of insulin resistance and diabetes

722

Cardiovascular Risk Estimation and Eligibility for Statins in Primary Prevention Comparing Different Strategies

723

Cardiovascular Risk Factor Control and Adherence to Recommended Lifestyle and Medical Therapies in Persons With Coronary Heart Disease (from the National Health and Nutrition Examination Survey 2007–2010)

724

Cardiovascular risk factor profiles and their social gradient from adolescence to age 74 in a Swiss region

725

Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial

726

Cardiovascular Risk Factors among Children after a 2image-Year Intervention—The CATCH Study

727

Cardiovascular risk factors among retired attendees visiting primary care clinics

728

Cardiovascular Risk Factors and Acculturation in Yaquis and Tepehuanos Indians from Mexico

729

Cardiovascular risk factors and alcohol consumption in France and Northern Ireland Original Research Article

730

Cardiovascular risk factors and confounders among nondrinking and moderate-drinking U.S. adults

731

Cardiovascular Risk Factors and Confounders Among Nondrinking and Moderate-Drinking U.S. Adults

732

Cardiovascular Risk Factors and Coronary Atherosclerosis in Retired National Football League Players

733

Cardiovascular Risk Factors and COVID-19 incidence- Result from a population based study

734

Cardiovascular risk factors and hyperinsulinemia in elderly men: The Honolulu Heart Program

735

CARDIOVASCULAR RISK FACTORS an‎d IN-HOSPITAL MORTALITY IN 1258 CASES OF CORONARY ARTERY BYPASS SURGERY IN TEHRAN HEART CENTER

736

Cardiovascular risk factors and migraine without aura: A case-control study.

737

Cardiovascular Risk Factors and Nutritional Intake are not Associated with Ultrasound-defi ned Increased Carotid Intima Media Thickness in Individuals Without a History of Cardiovascular Events

738

Cardiovascular Risk Factors and Specific Coronary Artery Calcification in Postmenopausal Women

739

Cardiovascular Risk Factors Are on the Rise in Developing Countries

740

Cardiovascular risk factors are really linked in the metabolic syndrome: This phenomenon suggests clustering rather than coincidence

741

Cardiovascular risk factors as determinants of endothelium-dependent and endothelium-independent vascular reactivity in the general population

742

Cardiovascular risk factors associated with enlarged diameter of the abdominal aortic and iliac arteries in healthy women

743

Cardiovascular risk factors associated with migraine

744

Cardiovascular Risk Factors Clustering Features of Insulin Resistance Syndrome (Syndrome X) in a Biracial (Black-White) Population of Children, Adolescents, and Young Adults The Bogalusa Heart Study

745

Cardiovascular Risk Factors Clustering Features of Insulin Resistance Syndrome (Syndrome X) in a Biracial (Black-White) Population of Children, Adolescents, and Young Adults The Bogalusa Heart Study

746

Cardiovascular Risk Factors Determine Erectile and Arterial Function Response to Sildenafil

747

Cardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarction

748

Cardiovascular Risk Factors in Adolescence: Prevalence and Familial Aggregation

749

Cardiovascular risk factors in ethnic minority women aged ≤30 years

750

Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients

751

Cardiovascular Risk Factors in Hypertension: Rationale and Design of Studies to Investigate the Effects of Controlled-Release Carvedilol on Regression of Left Ventricular Hypertrophy and Lipid Profile

752

Cardiovascular Risk Factors in Italy

753

Cardiovascular risk factors in Kuwaiti adults with type 2 diabetes

754

Cardiovascular risk factors in Montana American Indians with and without diabetes Original Research Article

755

Cardiovascular risk factors in non-insulin-dependent diabetics compared to non-diabetic controls: a population-based survey among Asians in Singapore Original Research Article

756

Cardiovascular risk factors in patients aged 85 or older with ischemic stroke

757

Cardiovascular risk factors in people abovetwenty years old in Gonabad, Iran

758

Cardiovascular risk factors in relation to cigarette smoking: a population-based survey among Asians in Singapore Original Research Article

759

Cardiovascular risk factors in Tanzania: a revisit

760

Cardiovascular risk factors in the urban Mexican population: The FRIMEX study

761

Cardiovascular Risk Factors in Young Patients of Coronary Artery Disease: Differences over a Decade

762

Cardiovascular risk factors in youth with implications for aging: The Bogalusa Heart Study

763

Cardiovascular risk factors of hypertension, smoking and obesity: Emerging concerns among Pathan and Persian young adults?

764

Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension

765

Cardiovascular Risk Factors: A Study on the Prevalence of MS among 11-18 Years Old School Children in East of Iran, 2012

766

Cardiovascular risk in a hypertension clinic-implications of the Sheffield Table for lipid-lowering strategy

767

Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration: A Systematic Meta-Analysis

768

Cardiovascular risk in long-term survivors of testicular cancer: Vaughn DJ, Palmer SC, Carver JR, Jacobs LA, Mohler ER, Department of Medicine, Hematology/Oncology Division, University of Pennsylvania, Philadelphia, PA; Department of Psychiatry, Universit

769

Cardiovascular Risk in Men Aged Over 40 in Boa Vista, Brazil

770

Cardiovascular risk in patients with bipolar disorder

771

Cardiovascular Risk in Patients With Fasting Blood Glucose Levels Within Normal Range

772

Cardiovascular Risk in Patients With Human Immunodeficiency Virus Infection: Incomplete Data

773

Cardiovascular risk in patients with plaque psoriasis and psoriatic arthritis without a clinically overt cardiovascular disease: the role of endothelial progenitor cells

774

Cardiovascular risk in rheumatoid arthritis

775

Cardiovascular Risk in Survivors of Stroke Original Research Article

776

Cardiovascular Risk in Women With Non-Specific Chest Pain (from the Womenʹs Health Initiative Hormone Trials)

777

Cardiovascular Risk in Women With PCOS

778

Cardiovascular risk management in clinical practice: the midwest heart specialists experience

779

Cardiovascular risk models; is there an ideal model?

780

Cardiovascular risk of antidepressant use in elderly medicare beneficiaries: Comparison by therapeutic class

781

Cardiovascular Risk Perception among Iranian Women with type 2 Diabetes Mellitus

782

Cardiovascular Risk Profile and Lifestyle Habits in a Cohort of Italian Cardiologists (from the SOCRATES Survey)

783

Cardiovascular Risk Profile of Apparently Healthy Workers in a Tertiary Hospital in Nigeria

784

Cardiovascular risk profiles in UK-born Caribbeans and Irish living in England and Wales

785

Cardiovascular Risk Profiles of Oral Contraceptive Users and Nonusers: A Population-Based Study

786

Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: The life study Original Research Article

787

Cardiovascular risk reductions associated with aggressive lifestyle modification and cardiac rehabilitation

788

Cardiovascular risk score in Rheumatoid Arthritis

789

Cardiovascular risk stratification by means of the SCORE system in health care workers in Veracruz, Mexico

790

Cardiovascular risk stratification of pulmonary embolism

791

Cardiovascular Risk Stratification With Plasma B-Type Natriuretic Peptide Levels in a Community-Based Hypertensive Cohort

792

Cardiovascular Risk-Factors in the Eastern Iranian Population: Are We Approaching 25×25 Target?

793

Cardiovascular risk-factors predict progression of urinary albumin-excretion in a general, non-diabetic population: A gender-specific follow-up study

794

CARDIOVASCULAR RISKS AMONG SHIFT AND NON-SHIFT WORKERS IN A PUBLIC MEDICAL CENTRE IN KUALA LUMPUR

795

Cardiovascular safety of cyclo-oxygenase-2 inhibitors

796

Cardiovascular safety of cyclo-oxygenase-2 inhibitors – Authorsʹ reply

797

Cardiovascular safety of fexofenadine HCI

798

Cardiovascular Safety of Fexofenadine HCl

799

Cardiovascular safety of maximal strength testing in healthy adults

800

Cardiovascular safety of rosiglitazone

801

Cardiovascular safety of sublingual apomorphine in patients on stable doses of oral antihypertensive agents and nitrates

802

Cardiovascular Safety Update of Tadalafil: Retrospective Analysis of Data from Placebo-Controlled and Open-Label Clinical Trials of Tadalafil With As Needed, Three Times-per-Week or Once-a-Day Dosing

803

Cardiovascular Screening and Emergency Procedures at Health Clubs and Fitness Centers

804

Cardiovascular sequelae of childhood hypertension

805

Cardiovascular solid mechanics. Cells, tissues, and organs: Jay D. Humphrey (Ed.); Springer verlag, New York, 2002, pp. 776, price US$99.00 hardback, ISBN 0-387-95168-7

806

Cardiovascular status of infants and children of women infected with HIV-1 (P2C2 HIV): a cohort study

807

Cardiovascular stent design and vessel stresses: a finite element analysis

808

Cardiovascular stents: overview, evolution, and next generation

809

Cardiovascular stress response and coronary artery disease: Evidence of an adverse postmenopausal effect in women, , , ,

810

Cardiovascular surgeonʹs remarks cause uproar in Spain

811

Cardiovascular system and intermittent stress: Bloodless adaptation to blood loss

812

Cardiovascular system is at higher risk of affecting by COVID-19

813

Cardiovascular targets for estrogens and phytoestrogens: Transcriptional regulation of nitric oxide synthase and antioxidant defense genes

814

Cardiovascular Therapies and Risk for Development of Diabetes Review Article

815

Cardiovascular therapy of neurosurgical patients

816

Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib

817

Cardiovascular tissue engineering

818

Cardiovascular Tissue Engineering Therapy: So Near, So Far?

819

Cardiovascular Toxicity of Nicotine: Implications for Nicotine Replacement Therapy

820

Cardiovascular Ultrasonographic Features and Clinical Findings for Intravenous Leiomyomatosis: A Case Report

821

Cardiovascular variability characteristics in obstructive sleep apnea

822

Cardiovascular variability during periodic leg movements: a spectral analysis approach

823

Cardiovascular, Antinociceptive and Sedative Effects of Medetomidine Infusion in Sevoflurane Anesthesia in Puppies

824

Cardiovascular, Haematological and Biochemical Responses After Large Volume Blood Collection in Horses

825

Cardiovascular, neuroendocrine, and monoaminergic responses to psychological stressors: Possible differences between remitted panic disorder patients and healthy controls

826

Cardiovascular, respiratory, and panic reactions to epinephrine in panic disorder patients

827

Cardiovascular-radical outcome method is effective in complex congenital cardiac lesions

828

Cardiovascular-Renal Responses to Long-Term Nitric Oxide Inhibition During Angiotensin II-AT1 Receptor Inhibition

829

Cardioversion for Atrial Fibrillation: Does Inflammation Matter?

830

Cardioversion of atrial fibrillation and its effect on right ventricular function as assessed by tricuspid annular motion

831

Cardioversion of atrial fibrillation in the elderly

832

Cardioversion of atrial fibrillation in the setting of mild to moderate heart failure

833

Cardioversion of atrial fibrillation to sinus rhythm: who, when, how, and why?

834

Cardioversion of Paroxysmal Atrial Fibrillation in the Emergency Department, ,

835

Cardioversion under the guidance of transesophageal echochardiograhy in persistent atrial fibrillation: results with low molecular weight heparin

836

Cardioversion With Novel Oral Anticoagulants: Reconfirming a 50-Year-Old Standard

837

Cardioverter defibrillator implantation in an adult with isolated noncompaction of the ventricular myocardium

838

Cardioverter-defibrillator implantation in the catheterization laboratory: Initial experiences in 48 patients

839

Cardioverter-defibrillator oversensing due to double counting of ventricular tachycardia electrograms

840

CardioVision 2020: Program Acceptance and Progress After 4 Years Original Research Article

841

Cardiovocal syndrome after transradial cardiac catheterization: An unusual complication

842

CardioWest Total Artificial Heart in a Moribund Adolescent With Left Ventricular Thrombi

843

CardioWest Total Artificial Heart: Bad Oeynhausen Experience

844

Cardiprotective effects of chronic hypoxia and preconditioning are not additive. Role of mitochondrial KATP channels

845

Cardo poly(arylene ether sulfone) block copolymers with pendant imidazolium side chains as novel anion exchange membranes for direct methanol alkaline fuel cell

846

Cardosin A as a model aspartic proteinase for the study of organic solvent effects: An overview on catalytic and structural aspects

847

Cardre to be absorbed into LCW after acquisition by Sensient Technologies

848

Cardré’s black iron oxide for eye make-up

849

Cardy states, factorization and idempotency in closed string field theory Original Research Article

850

Cardy–Verlinde formula and asymptotically de Sitter spaces

851

Cardy–Verlinde formula and thermodynamics of black holes in de Sitter spaces Original Research Article

852

Care after cure in leprosy

853

Care and cure. An integrated approach to psychosomatic medicine: A report from the second annual conference the EAPM, Sibiu, 2014

854

Care and despair in the UK National Health Service

855

Care and Do Not Harm: Possible Misunderstandings With Quaternary Prevention (P4); Comment on “Quaternary Prevention, an Answer of Family Doctors to Over Medicalization”

856

Care and feeding of reproducible econometrics

857

Care and NonCare‑Related Activities among Critical Care Nurses: A Cross‑Sectional Observational Time and Motion Study

858

Care and outcomes of elderly patients with acute myocardial infarction by physician specialty: the effects of comorbidity and functional limitations

859

Care and Support for Adolescents Living with HIV/AIDS in School Settings: Perspectives of Teachers and Administrators in the Southern Highlands of Tanzania

860

Care and Use of Diamond Knives

861

Care at first-level facilities for children with severe pneumonia in Bangladesh: a cohort study

862

Care Burden in Parents of Children with Leukemia: A Cross-Sectional Study in the West of Iran

863

Care concordant with guidelines predicts decreased long-term mortality in patients with unstable angina pectoris and non–ST-Elevation myocardial infarction

864

Care delivery innovation in an integrated health system

865

Care Dependency and Diabetes Self-Care Activities in Elderly Individuals with Diabetes

866

Care disparities: Moving from gray to black and white

867

Care emerges from chaos

868

Care for elderly in USA goes subacute

869

Care for Evidence-Based Applications During Pregnancy

870

Care for stroke patients

871

Care for stroke patients

872

Care for stroke patients

873

Care in comatose surviors of cardiac arrest

874

Care in the community

875

Care Instability in Nursing Homes; A Qualitative Study

876

Care Integration – From “One Size Fits All” to Person Centred Care; Comment on “Achieving Integrated Care for Older People: Shuffling the Deckchairs or Making the System Watertight for the Future?”

877

Care Management Challenges for Diabetic Foot Ulcers: A Qualitative Study

878

Care meanings, expressions, and experiences of those with chronic mental illness

879

Care needs and point prevalence of post-acute patients in the acute medical wards of an Italian hospital

880

Care needs and preferences from the perspective of COVID-19 patients: A qualitative study

881

Care Needs in the Phase I of Cardiac Rehabilitation: A Hybrid Concept Analysis

882

Care Needs of Children with Inborn Errors of Metabolism and Their Parents: An Integrative Review

883

Care Needs of Patients with Cancer; a Systematic Review

884

Care of acute myocardial infarction by nonivasive and invasive cardiologist: Procedure use, cost and outcome

885

Care of burns victims in Europe

886

Care of cardiac surgical patients

887

Care of children who have had surgery for congenital heart disease

888

CARE OF DEMENTIA IN CANADA: A COLLABORATIVE CARE APPROACH WITH A CENTRAL ROLE FOR THE PRIMARY CARE PHYSICIAN

889

Care of Diabetic Retinopathy Patients in Oman

890

Care of handicapped in Gaza

891

Care of learning-disabled Russian children condemned

892

Care of Minor Injuries by Emergence Nurse Practitioners or Junior Doctors: A Randomised Controlled Trial

893

Care of minor injuries by emergency nurse practitioners or junior doctors: a randomised controlled trial Original Research Article

894

Care of non-ST-segment elevation patients: Insights from the crusade national quality improvement initiative

895

Care of older people in nursing homes: an Intensive Programme as an educational activity within Erasmus–Socrates

896

Care of terminally-ill patients: an opinion survey among critical care healthcare providers in the Middle East

897

Care of the adult with congenital heart disease: introduction

898

Care of the Athlete With Type 1 Diabetes Mellitus: A Clinical Review

899

Care of the critically ill parturient: oliguria and renal failure

900

Care of the elderly with gastrointestinal problems in family practice

901

Care of the end-stage renal disease patient on dialysis in the ED

902

Care of the organization: Training and development strategies

903

Care of the pacemaker/implantable cardioverter defibrillator patient in the ED

904

Care of the patient close to death

905

Care of the renal transplant recipient in the emergency department

906

Care of the woman with hypertension in pregnancy: the viewpoint of the midwife

907

Care or control: health or criminal justice options for the long-term seriously mentally ill in a Canadian province

908

Care or scare: The safety of youth in congregate care in New York City

909

Care pathways for south Asian and white people with depressive and anxiety disorders in the community

910

Care pathways in thrombosis management: the INNOVATE peer-to-peer educational initiative

911

Care process and satisfaction analysis of a transmural home care program Original Research Article

912

Care Process in Iranian Nursing Homes: A Grounded Theory Study

913

Care Providers’ Perspectives on Quality Prenatal Care in High-risk Pregnancies: A Qualitative Study

914

Care provision and community adjustment of rural consumers with serious mental illness

915

Care seeking in Sri Lanka: one possible explanation for low childhood mortality

916

Care Seeking Patterns of STIs-Associated Symptoms in Iran: Findings of a Population-Based Survey

917

Care Seeking Practices of Mothers Regarding Four Key Family Practices Related to Child Health and Development

918

Care to be a nurse? Reflections on a radio broadcast and its ramifications for nursing today

919

Care Work Migration in Germany: Semi-Compliance and Complicity

920

CARE: an automobile crash data analysis tool

921

Carebene and isocyanide ligation at ruthenium(II) with (η6-arene) and tethered phosphinopropylarene ligands

922

CAREdose 4D Application in Brain CT Scan: The Effect on Dose and Image Quality

923

Career advancement and scientific performance in universities

924

Career analysis: a case study of hotel general managers in Australia

925

Career anchors and disturbances in job turnover decisions – A case study of IT professionals in Taiwan

926

Career anchors and paths: The case of Gay, Lesbian, & Bisexual workers

927

Career Aspirations And Pregnancy Intentions In Pregnant Teens

928

Career atifaction and urgical practice pattern among female ophthalmologit

929

Career choices for career growth

930

Career choices in health care: Is nursing a special case? A content analysis of survey data

931

Career concerns and mandated disclosure

932

Career concerns in a simple experimental labour market

933

CAREER CONSULTATION AS AN INTERVENTION STRATEGY IN ALLEVIATING FAMILY’S MENTAL HEALTH: A CASE STUDY ON STUDENTS WITH DISABILITIES

934

Career Counseling For Management Students

935

CAREER COUNSELLING FOR CLIENTS WITH PHYSICAL DISABILITIES IN MALAYSIAN CONTEXT

936

Career Decision-Making Self-Efficacy and Its Implications in High School Students during the Covid-19 Pandemic

937

Career decisions: The interim option

938

Career development for infection and immunity research in Uganda: a decade of experience from the Makerere University – Uganda Virus Research Institute research and training programme

939

Career development in organizations and beyond: Balancing traditional and contemporary viewpoints

940

Career development of female managers in retailing: Inhibitors and enablers

941

Career Development of Nursing Preceptors in Iran: A Descriptive Study

942

Career Development of School Psychologists

943

Career Development through E-Learning: The Importance of a Competence-Based Learning Approach

944

Career Dis-integration and Re-integration in Mergers and Acquisitions:: Managing Competence and Motivational Intangibles

945

Career Education in the Primary Grades: Building Work-Readiness Through an Experiential Curriculum

946

Career Guidance Methods for Increasing Career Maturity in Grade IX Students at SMPN 15 Yogyakarta

947

Career guidancefor student nurses: an unmet need

948

Career Indecision and Career Anxiety in High School Students: An Investigation through Structural Equation Modelling

949

CAREER MANAGEMENT COMPETENCY AMONG VOCATIONAL SKILLED MILITARY RETIREES

950

Career management of business expatriates from China

951

Career mothers and perfectionism: stress at work and at home

952

CAREER MOVES: TRANSFER AND RANK CHALLENGE DECISIONS BY MALE LONG-TAILED MACAQUES

953

Career Obstacles of Working Women: A Research in Eskişehir

954

Career options in aerospace and aviation medicine

955

Career orientations and career success among research, and development and engineering professionals

956

Career orientations of information systems employees in South Africa

957

Career paths beyond nursing and the contribution of nursing experience and skills in attaining these positions

958

Career paths for the 21st century. How to beat job insecurity: Jim Duncan and David Oates, Century Business (1996), £12.99

959

Career Paths to Public Health: Programs at the Centers for Disease Control and Prevention Review Article

960

Career Perception at the Republic Indonesian Police Organization Impact of Distributive Fairness, Procedural Fairness and Career Satisfaction on Affective Commitment

961

Career planning and job searching in the information age : edited by Elizabeth A. Lorenzen. Binghampton, NY: Haworth Press, 1996 (simultaneously published as The Reference Librarian, no. 55). 120p. $29.95. ISBN 1-56024-838-6

962

CAREER PLANNING BY THE DOCTORS IN NWFP

963

Career plans and work perceptions of preservice teachers

964

Career plateauing and work attitudes: Moderating effects of mentoring others with Nigerian employees

965

Career preferences and the work–family balance in medicine: gender differences among medical specialists

966

Career profile of dentists in Saudi Arabia

967

Career progress of recent tourism graduates

968

Career prospects for female university researchers have not improved

969

Career Research Productivity Patterns of Marketing Academicians

970

Career Selection: Role of Parent’s Profession, Mass Media and Personal Choice

971

Career Self-Efficacy Among African-American Female Adolescents

972

Career skills gained from an international equine experience

973

Career stress responses among hospitality employees

974

Career Women as a Role Model in the Formation of Morals

975

Career, experience and returns to human capital: is the dual labour market hypothesis relevant for the UK?

976

Careers and clusters: analyzing the career network dynamic of biotechnology clusters

977

Careers and human resource management—a European perspective

978

Careers and lives socialization, structural lag, and gendered ambivalence

979

Careers and mortality in France: evidence on how far occupational mobility predicts differentiated risks

980

Careers in Medicine or what do you want when you grow up?

981

Careers in science: policy issues according to Nature and Science editorials

982

Careers in the next millennium: directions for future research

983

Careers within careers: Reconceptualizing the nature of career anchors and their consequence

984

Careful considerations when reporting and evaluating the grey water footprint of products

985

Careful Co-Planning for Effective Team Teaching in Mathematics

986

Careful naming of disorders

987

Careful partial harvesting in conservation stands and retention of large oaks favour oak regeneration Original Research Article

988

Care-full markets? A reply to John Christman and Veronica Crossa

989

Caregiver and peer responses to children with language and motor disabilities in inclusive preschool programs

990

Caregiver attributions are not just for children: Evidence for generalized low power schemas

991

Caregiver burden among Iranian heart failure family caregivers: A descriptive, exploratory, qualitative study

992

Caregiver burden among Japanese informal caregivers of cognitively impaired elderly in community settings

993

Caregiver Burden among Parents of Hearing Impaired and Intel- lectually Disabled Children in Pakistan

994

Caregiver burden and coping

995

Caregiver burden and disability in somatization disorder

996

Caregiver burden and health promotion

997

Caregiver Burden and Its Associated Factors in Caregivers of Children and Adolescents with Chronic Conditions

998

Caregiver Burden and its Determinants among the Family Members of Patients with Dementia in Iran

999

Caregiver burden and outcomes of caregiving of spouses of patients who undergo coronary artery bypass graft surgery

1000

Caregiver Burden and Quality of Life among Caregivers of Cancer Patients in Ahvaz, 2021 - 2022: A Cross-Sectional Study